Hims & Hers (HIMS) Down 21% - Is the GLP-1 Gravy Train Over?Hims & Hers Health faces a significant stock drop due to the end of the Ozempic shortage, impacting its compounded drug market.
Hims & Hers stock tanks as Amazon debuts fixed pricing for hair loss and erectile dysfunction drugsHims & Hers Health's stock plummets due to Amazon's expansion in telehealth services.
Has Eli Lilly Destroyed Hims & Hers Upside?Hims & Hers Health capitalized on weight-loss drug market trends while facing new competition from Eli Lilly's FDA-approved product offerings.
Why Hims & Hers Health (HIMS), Tempus AI (TEM) and Teladoc (TDOC) Are Up Big TodayConsumer inflation expectations in 2025 may hinder Fed rate cuts, affecting stock markets.
Hims & Hers (HIMS) Down 21% - Is the GLP-1 Gravy Train Over?Hims & Hers Health faces a significant stock drop due to the end of the Ozempic shortage, impacting its compounded drug market.
Hims & Hers stock tanks as Amazon debuts fixed pricing for hair loss and erectile dysfunction drugsHims & Hers Health's stock plummets due to Amazon's expansion in telehealth services.
Has Eli Lilly Destroyed Hims & Hers Upside?Hims & Hers Health capitalized on weight-loss drug market trends while facing new competition from Eli Lilly's FDA-approved product offerings.
Why Hims & Hers Health (HIMS), Tempus AI (TEM) and Teladoc (TDOC) Are Up Big TodayConsumer inflation expectations in 2025 may hinder Fed rate cuts, affecting stock markets.
What Is Hims Actually Selling?Hims & Hers Health's Super Bowl ad represents a shift towards addressing broader grievances and selling weight-loss solutions for both genders.
Hims & Hers says it's selling a GLP-1 weight loss drug for 85% less than Wegovy. Here's the price.Hims & Hers Health offers GLP-1 weight loss drugs at a fraction of the cost of brand-name competitors, leading to a significant increase in shares.
What Is Hims Actually Selling?Hims & Hers Health's Super Bowl ad represents a shift towards addressing broader grievances and selling weight-loss solutions for both genders.
Hims & Hers says it's selling a GLP-1 weight loss drug for 85% less than Wegovy. Here's the price.Hims & Hers Health offers GLP-1 weight loss drugs at a fraction of the cost of brand-name competitors, leading to a significant increase in shares.
Hims & Hers Health stock price nears record high on news that it will offer GLP-1 weight-loss drugs amid shortagesHims & Hers Health announced the addition of GLP-1 injectable drugs to its offerings at significantly reduced prices, leading to a surge in stock prices.